Atlas Bio
Atlas Bio develops AI models that simulate patient responses to help biopharma teams assess drug development decisions.
$10MSeed
LeadC
Creandum
Activity from announced rounds
Activity in this selectionOct 28, 2026 · Jul 31, 2026
Creandum is an investment firm whose official company profiles identify Rillet and Jack & Jill, both associated with partner Peter Specht.
Recorded funding activity
Rillet combines finance teams and agents in accounting software. Jack & Jill pairs a job-seeker career agent with an employer recruiting agent, while Procuros connects companies with supply-chain trading partners. Their financing histories preserve the different customer workflows.
Sources
- Rounds participated in
- 8
- Confirmed lead rounds
- 2 1 roles undisclosed
- New companies
- 7 First participation on record · 1 follow-on
- Funding in participating rounds
- $572M 7 disclosed · full round size, not this investor’s share
By stage
By primary sector
2 more
Healthtech1
Robotics1
By country
Rounds
8 in this selectionMachenta
Machenta develops AI models that help robots learn physical tasks from demonstrations.
$40MSeed
LeadCausa Prima
AI agents that coordinate invoices, payment terms and cash management between companies.
$20MSeed
ParticipantScarlet
Certification services for software and AI medical devices.
$50MSeries B
ParticipantProcuros
An AI-native platform that connects companies and their supply-chain trading partners.
€20MSeries A
ParticipantJack & Jill
A two-sided recruiting service pairing Jack, an AI career agent for job seekers, with Jill, an AI recruiter for employers, to find suitable matches and make direct introductions.
$40MSeries A
ParticipantRillet
Rillet provides accounting software in which finance teams and AI agents work from a shared general ledger.
$100MSeries C
ParticipantOlix
Develops optical digital processors specialized for AI inference workloads
$312MSeries B
Role not disclosed